Home > Healthcare & Medical Devices > Softgel Capsules Market

Softgel Capsules Market Size By Type (Gelatin Based, Vegetarian Capsules), By Application (Prescription Medicines {Antibiotics & Antivirals, Cough & Cold Drugs} Health & Dietary Supplements {Vitamins, Enzymes, Omega 3, Minerals}), By Manufacturers (Pharmaceutical Companies, Nutraceutical Companies), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 – 2030

  • Report ID: GMI5272
  • Published Date: May 2022
  • Report Format: PDF

Industry Overview

Softgel Capsules Market size surpassed USD 8.2 billion in 2021 and is expected to witness 5.2% CAGR from 2022 to 2030. Growing prevalence of several chronic disorders such as cardiovascular diseases and risk of infections among others and increasing demand for advanced drug therapies are some of the prominent factors that contributed to the overall market growth.

Get more details on this report - Request Free Sample PDF

For instance, according to the American College of Cardiology, more than 523 million individuals were suffering from several cardiovascular disorders worldwide. Thus, the rising chronic disease burden will enhance the demand for softgel capsules for patient treatment. Furthermore, increasing product launches providing effective disease treatment for several diseases will proliferate softgel capsules industry outlook.

Moreover, extensive R&D efforts by numerous organizations will favor new product launches. Thus, expanding the availability of novel softgel capsules across emerging economies with the introduction of innovative products will impel the market growth during the forecast period. Furthermore, the growing geriatric population that is prone to age-related diseases is another prominent factor that will accelerate softgel capsules industry growth over the estimated period.

The COVID-19 outbreak has positively impacted the softgel capsules market share due to high demand for vitamin and health supplements. Additionally, increased demand for immune system boosters during pandemic has boosted the demand for health & dietary supplement. Therefore, amid the pandemic, high demand for vitamin softgel capsules has strengthened revenue size. Moreover, growing population trend toward a healthy lifestyle has stimulated demand for diet supplements during the pandemic and helped the industry to grow substantially in past years.

Softgel capsules are a type of capsule dosage form for oral drug administration. These capsules are mainly made up of gelatin, pullulan, HPMC, potato starch, pectin and others. Softgel capsules are utilized to contain medicine in the form of liquid semisolid or solid that dissolves more quickly in the gastric juices of the stomach than a hard gelatin capsule. These are widely used in the formulation of poorly soluble drugs for an enhanced absorption rate.

Continuous advancements in manufacturing technology will propel the softgel capsules market momentum

Continuous technological advancements in the softgel capsules manufacturing field are one of the major factors accelerating the softgel capsules market growth. Growing adoption of novel products such as hydroxypropyl methylcellulose (HPMC), potato starch, pullulan, pectin, and others in softgel manufacturing will boost the industry growth potential. Moreover, advancements in softgel capsules offer several benefits including enhanced stability, absorption rate, high bioavailability, solubility, better dissolution rate with a reduced health risk will boost the product demand.

Further, several manufacturers are involved in R&D activities to create innovative empty softgel capsules that are more versatile and convenient for nutraceutical, pharmaceutical, and cosmeceutical uses will proliferate the market growth. These market participants are more likely to favor numerous empty softgel capsules owing to their compatibility for various formulations such as liquid and solid dosage forms, as well as their ease-of-use properties while administering medications orally or through inhalation routes.

Enhanced availability of numerous softgel capsule products with highly advanced features such as chewcaps, duocaps, hydrophilic sandwich (HS) capsules, and several others are impelling the market demand.

High demand for soft gelatin capsules owing to several benefits has boosted the segmental demand

Get more details on this report - Request Free Sample PDF

Based on type, the gelatin based softgel capsules dominated the segment and accounted for more than USD 7.5 billion revenue in 2021 due to the high prevalence of several chronic diseases such as infections and cardiovascular diseases among others worldwide. Moreover, high adoption of softgel capsules due to numerous advantages such as taste masking, ease of swallowing and longer shelf life will impel the segmental growth. Further, high preference of nutraceutical and pharmaceutical manufacturers toward gelatin based empty capsules for different formulations due to ease of use and non-reactive nature is expected to accelerate softgel capsules market revenue.

Growing health-consciousness among the population will impel the segmental expansion

Get more details on this report - Request Free Sample PDF

Based on application, the health and dietary segment held more than 65% market share in 2021. Increasing usage of vitamins and minerals to boost immunity in past years will drive segmental growth. Additionally, growing health-consciousness among populations across the world will boost the demand for dietary supplements such as omega 3 and others. Further, the sudden upsurge in the adoption of vitamins during COVID-19 pandemic has boosted the market statistics.

Continuous product launches coupled with high adoption of technological advancements will propel the segmental landscape

Based on manufacturers, the pharmaceutical companies segment garnered more than USD 2 billion in revenue in 2021 and will grow lucratively over the anticipated period, owing to the enhanced availability of softgel capsules for several types of disease treatment. Also, the large presence of pharmaceutical companies in the market involved in novel drug development to cater to the better patient outcome will strengthen the softgel capsules market size.

Moreover, several organizations are implanting numerous growth strategies to expand their market reach will bolster the market growth. For instance, in October 2019, Sirio Pharma launched a range of plant-based solutions such as pectin and red algae for its entire offering of softgel capsules, gummies, hard shell capsules and others. This has offered development opportunities to the firm.

Strong presence of key industry players in North America will strengthen the overall market growth potential

Get more details on this report - Request Free Sample PDF

North America softgel capsules market is anticipated to flourish at 4.9% CAGR over the estimated timeframe. Growing prevalence of several chronic diseases in the region will stimulate the demand for softgel capsules. Further, the high adoption of softgel capsules owing to several benefits is expected to contribute to regional market expansion.

Also, the strong presence of several organizations in the region that are proactively involved in novel drug manufacturing will boost overall market demand. Growing awareness related to advanced doses form in several disease treatments will spur market growth. Furthermore, rising healthcare expenditure, high disposable income and favorable reimbursement scenario are predicted to propel the softgel capsules market value potential in forthcoming years.

Several collaborations and product launches will offer enormous growth opportunities to the market players

Some of the notable market players operating in the softgel capsules industry include Eurocaps Ltd., Catalent Inc., Capsugel (Lonza), Aenova Group GmbH, Sirio Pharma Co., Procaps Group, Captek Softgel International Inc., Patheon, Fuji capsules Co., Ltd., Curtis Health Caps, Delpharm Evreux, Guangdong Yichao Biological Co., Ltd., and Estrellus among others. These industry players are implementing numerous growth strategies such as collaboration, acquisition & merger, partnership and product launch to gain competitive edge over others in softgel capsules industry.

Some of the recent industry developments:

  • In August 2021, Catalent, Inc. has announced the acquisition of Bettera Holdings, LLC, a prominent manufacturer in the nutritional supplements market. these has strengthened company’s softgel product portfolio and broadened manufacturing capabilities.
  • In October 2021, Aenova with AlaskOmega AG, and Algarithm developed and manufacturing VegaGels that are filled with omega-3 DHA fatty acids from microalgae. These capsules are vegan and chewable in nature. Such product developments have enlarged company’s product offerings.

The softgel capsules market report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2022 to 2030, for the following segments:

By Type

  • Gelatin based
  • Vegetarian capsules

By Application

  •  Health & dietary supplements
    • Vitamins
    • Enzymes
    • Omega 3
    • Minerals
    • Others
  • Prescription medicines
    • Antibiotics & antivirals
    • Cough & cold drugs
    • Others

By manufacturers

  • Pharmaceutical companies
  • Nutraceutical companies
  • Others

The above information is provided for the following regions and countries:

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • UAE


Authors: Rupali Swain, Subodh Kharad

Frequently Asked Questions (FAQ) :

Global market for softgel capsules surpassed USD 8.2 billion in 2021 and is expected to record a CAGR of 5.2% between 2022 and 2030 owing to the rising prevalence of numerous chronic diseases.
Gelatin-based softgel capsules demand exceeded USD 7.5 billion in 2021 and will depict lucrative growth considering the increasing incidences of cardiovascular diseases across the globe.
North American market for softgel capsules is estimated to grow at a CAGR of 4.9% through 2030 driven by the robust presence of several novel drug manufacturing organizations in the region.
Key players in the softgel capsules industry comprise Procaps Group, Catalent Inc., Estrellus, Curtis Health Caps, Delpharm Evreux, Guangdong Yichao Biological Co., Ltd., and others.

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2021
  • Companies covered: 13
  • Tables & Figures: 204
  • Countries covered: 18
  • Pages: 205
  • Upcoming Report: Details can be customized to meet your information and data needs. Feel free to share your detailed research requirements via this form.

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount